Michael Hebert sees some potential trouble ahead:
So what’s the problem, critics may ask. Cheaper drugs for more people. The American way. But there is a possible problem. If Wal-Mart’Â’s list becomes everybody’s list, that means Wal-Mart is setting national health care policy. Put another way, someone at Wal-Mart will be deciding if your blood pressure will be treated with atenolol or metoprolol. Or if, after a root canal, your dentist will send you home with Lortab or Darvocet. In that light, it may matter just a little.
